About Excelra
Excelra is a company based in Hyderabad (India) founded in 2001.. Excelra has raised $163.84 thousand across 1 funding round from investors including Destiny Investments. The company has 622 employees as of April 01, 2024. Excelra has completed 1 acquisition, including BISC Global. Excelra offers products and services including GOSTAR™ Small Molecules, BioVisualizer™, and Online Pipeline Platform (OP²)®. Excelra operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Hyderabad, India
- Employees 622 as on 01 Apr, 2024
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Excelra Knowledge Solutions Private Limited
- Date of Incorporation 24 Feb, 2006
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$34.4 M (USD)0as on Mar 31, 2023
-
Net Profit
$7.42 M (USD)0as on Mar 31, 2023
-
EBITDA
$10.57 M (USD)0as on Mar 31, 2023
-
Total Equity Funding
$163.84 K (USD)
in 1 rounds
-
Latest Funding Round
$163.84 K (USD), Seed
Jul 29, 2016
- Investors
-
Employee Count
622
as on Apr 01, 2024
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Excelra
Excelra offers a comprehensive portfolio of products and services, including GOSTAR™ Small Molecules, BioVisualizer™, and Online Pipeline Platform (OP²)®. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
SAR database for small molecule drug discovery and analysis
Platform for visualizing and analyzing biomedical data
No-code tool for sequencing data processing and insights
Unlock access to complete
Funding Insights of Excelra
Excelra has successfully raised a total of $163.84K through 1 strategic funding round. The most recent funding activity was a Seed round of $163.84 thousand completed in July 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $163,836
-
First Round
First Round
(29 Jul 2016)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2016 | Amount | Seed - Excelra | Valuation | Destiny Investments |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Excelra
Excelra has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Destiny Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Provides comprehensive investment advisory services to help clients achieve financial goals.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Excelra
Excelra has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include BISC Global. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bioinformatics and biostatistics services are provided to life science firms.
|
2017 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Excelra
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Excelra Comparisons
Competitors of Excelra
Excelra operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Excelra
Frequently Asked Questions about Excelra
When was Excelra founded?
Excelra was founded in 2001 and raised its 1st funding round 15 years after it was founded.
Where is Excelra located?
Excelra is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Who is the current CEO of Excelra?
Anandbir Singh Brar is the current CEO of Excelra.
Is Excelra a funded company?
Excelra is a funded company, having raised a total of $163.84K across 1 funding round to date. The company's 1st funding round was a Seed of $163.84K, raised on Jul 29, 2016.
How many employees does Excelra have?
As of Apr 01, 2024, the latest employee count at Excelra is 622.
What is the annual revenue of Excelra?
Annual revenue of Excelra is $34.4M as on Mar 31, 2023.
What does Excelra do?
Excelra develops a bioinformatics platform for the in silico analysis of drug candidate. The companys product GOSTAR is a SAR database that provides information on SAR, ADME, toxicity, preclinical, clinical, and structural data, GOBIOM is a repository of biomarkers reported in pre-clinical, clinical and exploratory phases, CTOD is a Clinical Trial Outcome Database. The company also develops and markets a suite of clinical trial outcomes databases. It also develops clinical databases that support MBMA on a custom basis. It also offers services for drug and biomarker discovery. It was previously known as GVK Informatics.
Who are the top competitors of Excelra?
Excelra's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Excelra offer?
Excelra offers GOSTAR™ Small Molecules, BioVisualizer™, and Online Pipeline Platform (OP²)®.
How many acquisitions has Excelra made?
Excelra has made 1 acquisition, including BISC Global.
Who are Excelra's investors?
Excelra has 1 investor. Key investors include Destiny Investments.